Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Change in Receivables (2024 - 2025)

Beta Bionics' Change in Receivables history spans 2 years, with the latest figure at $5.6 million for Q4 2025.

  • For Q4 2025, Change in Receivables rose 22.75% year-over-year to $5.6 million; the TTM value through Dec 2025 reached $5.2 million, down 32.24%, while the annual FY2025 figure was $5.2 million, 32.24% down from the prior year.
  • Change in Receivables for Q4 2025 was $5.6 million at Beta Bionics, up from $168000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $5.6 million in Q4 2025 and bottomed at -$2.9 million in Q1 2025.